COVID-19 Vaccines May Help Cancer Patients, Researchers Say

A clinical trial is necessary to confirm the preliminary findings, the researchers said.

A tray with a Pfizer-BioNTech COVID-19 vaccine is seen at a health care center in Miami on May 29, 2025. Joe Raedle/Getty Images

Patients with a particular form of lung cancer who received a COVID-19 vaccine lived longer than those who did not, researchers said in a new study.

Patients who received a Pfizer-BioNTech or Moderna COVID-19 vaccine within 100 days of starting immunotherapy drugs survived longer on average than patients who did not, researchers with the University of Florida and University of Texas said in the paper, which was published by Nature on Oct. 22.